Xianggui Yuan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xianggui Yuan

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Neuro-Oncology Advances|June 22, 2026

The prognostic role of surgical resection in selected patients with primary CNS lymphoma based on voxel-wise analysisZhangqi Dou, Jiawei Wu, Xianggui Yuan, et al.

Nature Cancer|April 18, 2025

Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trialWen Lei, Hui Liu, Wenhai Deng, et al.

American Journal of Hematology|June 8, 2026

Integrated Genomic and Tumor Microenvironment Subtyping Improved Risk Stratification in Primary Central Nervous System LymphomaXianggui Yuan, Qian Luo, Yurong Huang, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Neuro-Oncology Advances|June 22, 2026

The prognostic role of surgical resection in selected patients with primary CNS lymphoma based on voxel-wise analysisZhangqi Dou, Jiawei Wu, Xianggui Yuan, et al.

Nature Cancer|April 18, 2025

Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trialWen Lei, Hui Liu, Wenhai Deng, et al.

American Journal of Hematology|June 8, 2026

Integrated Genomic and Tumor Microenvironment Subtyping Improved Risk Stratification in Primary Central Nervous System LymphomaXianggui Yuan, Qian Luo, Yurong Huang, et al.

Pageof 2